MENU
MIRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Mirum Pharmaceuticals (MIRM) Ownership - Who owns Mirum Pharmaceuticals?
Profile
Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.05B
P/E Ratio
N/A
Total Cash
284.45M
Projected Growth
N/A
Total Debt
317.65M
Revenue
307.03M
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash/Share
5.93
Total Debt/Equity
N/A
Revenue/Share
7.23 USD as % of share price
Fundamentals
MIRM
Capitalization
2.05B
P/E Ratio
N/A
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash
284M
Total Cash/Share
5.93
Total Debt
318M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
7.23%
Revenue
307M
ROE
N/A
Book Value
232M
P/B Ratio
8.40
Cash Flow
N/A
Earnings
-2.08
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
3.34
Current Revenue Per Employee
290601.28
Dividends Per Share - Security
N/A
EBITDA
-60.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
76.98
Revenue To Assets
-15.14
Shares Held By Institutions
3.27B
Shares Outstanding - Current
48M
Total Liabilities
436M
Total Volume MTD
N/A
Value
N/A
Gain YTD
44.478
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company. which focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
950 Tower Lane
Phone
+1 650 667-4085
Employees
264
Web
https://www.mirumpharma.com